|
1
|
Havel RJ, Eder HA and Bragdon JH: The
distribution and chemical composition of ultracentrifugally
separated lipoproteins in human serum. J Clin Invest. 34:1345–1353.
1955. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kontush A and Chapman MJ: Antiatherogenic
small, dense HDL–guardian angel of the arterial wall. Nat Clin
Pract Cardiovasc Med. 3:144–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davidson WS and Thompson TB: The structure
of apolipoprotein A-I in high density lipoproteins. J Biol Chem.
282:22249–22253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kontush A and Chapman MJ: Functionally
defective high-density lipoprotein: A new therapeutic target at the
crossroads of dyslipidemia, inflammation, and atherosclerosis.
Pharmacol Rev. 58:342–374. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karlsson H, Leanderson P, Tagesson C and
Lindahl M: Lipoproteomics II: Mapping of proteins in high-density
lipoprotein using two-dimensional gel electrophoresis and mass
spectrometry. Proteomics. 5:1431–1445. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heller M, Stalder D, Schlappritzi E, Hayn
G, Matter U and Haeberli A: Mass spectrometry-based analytical
tools for the molecular protein characterization of human plasma
lipoproteins. Proteomics. 5:2619–2630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rezaee F, Casetta B, Levels JH, Speijer D
and Meijers JC: Proteomic analysis of high-density lipoprotein.
Proteomics. 6:721–730. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaisar T, Pennathur S, Green PS, Gharib
SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P,
et al: Shotgun proteomics implicates protease inhibition and
complement activation in the antiinflammatory properties of HDL. J
Clin Invest. 117:746–756. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan Y, Liu TR, Hu SW, Tian D, Li C, Zhong
JK, Sun HG, Luo TT, Lai WY and Guo ZG: Acute coronary syndrome
remodels the protein cargo and functions of high-density
lipoprotein subfractions. PLoS One. 9:e942642014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan LR, Wang DX, Liu H, Zhang XX, Zhao H,
Hua L, Xu P and Li YS: A pro-atherogenic HDL profile in coronary
heart disease patients: An iTRAQ labelling-based proteomic
approach. PLoS One. 9:e983682014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lepedda AJ, Nieddu G, Zinellu E, De Muro
P, Piredda F, Guarino A, Spirito R, Carta F, Turrini F and Formato
M: Proteomic analysis of plasma-purified VLDL, LDL, and HDL
fractions from atherosclerotic patients undergoing carotid
endarterectomy: Identification of serum amyloid A as a potential
marker. Oxid Med Cell Longev. 385214:2013. View Article : Google Scholar
|
|
12
|
Ståhlman M, Fagerberg B, Adiels M, Ekroos
K, Chapman JM, Kontush A and Borén J: Dyslipidemia, but not
hyperglycemia and insulin resistance, is associated with marked
alterations in the HDL lipidome in type 2 diabetic subjects in the
DIWA cohort: Impact on small HDL particles. Biochim Biophys Acta.
1831:1609–1617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holzer M, Birner-Gruenberger R, Stojakovic
T, El-Gamal D, Binder V, Wadsack C, Heinemann A and Marsche G:
Uremia alters HDL composition and function. J Am Soc Nephrol.
22:1631–1641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mangé A, Goux A, Badiou S, Patrier L,
Canaud B, Maudelonde T, Cristol JP and Solassol J: HDL proteome in
hemodialysis patients: A quantitative nanoflow liquid
chromatography-tandem mass spectrometry approach. PLoS One.
7:e341072012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kopecky C, Genser B, Drechsler C, Krane V,
Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD and
Weichhart T: Quantification of HDL proteins, cardiac events, and
mortality in patients with type 2 diabetes on hemodialysis. Clin J
Am Soc Nephrol. 10:224–231. 2015. View Article : Google Scholar :
|
|
16
|
Watanabe J, Charles-Schoeman C, Miao Y,
Elashoff D, Lee YY, Katselis G, Lee TD and Reddy ST: Proteomic
profiling following immunoaffinity capture of high-density
lipoprotein: Association of acute-phase proteins and complement
factors with proinflammatory high-density lipoprotein in rheumatoid
arthritis. Arthritis Rheum. 64:1828–1837. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chait A, Han CY, Oram JF and Heinecke JW:
Thematic review series: The immune system and atherogenesis.
Lipoprotein-associated inflammatory proteins: Markers or mediators
of cardiovascular disease. J Lipid Res. 46:389–403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chei CL, Yamagishi K, Kitamura A, Kiyama
M, Imano H, Ohira T, Cui R, Tanigawa T, Sankai T, Ishikawa Y, et
al: CIRCS Investigators: High-density lipoprotein subclasses and
risk of stroke and its subtypes in Japanese population: The
Circulatory Risk in Communities Study. Stroke. 44:327–333. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ashby DT, Rye KA, Clay MA, Vadas MA,
Gamble JR and Barter PJ: Factors influencing the ability of HDL to
inhibit expression of vascular cell adhesion molecule-1 in
endothelial cells. Arterioscler Thromb Vasc Biol. 18:1450–1455.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barter PJ, Nicholls S, Rye KA,
Anantharamaiah GM, Navab M and Fogelman AM: Antiinflammatory
properties of HDL. Circ Res. 95:764–772. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fisher CM: The arterial lesions underlying
lacunes. Acta Neuropathol. 12:1–15. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogata J, Yamanishi H and Ishibashi-Ueda H:
Review: Role of cerebral vessels in ischaemic injury of the brain.
Neuropathol Appl Neurobiol. 37:40–55. 2011. View Article : Google Scholar
|
|
23
|
Sorci-Thomas MG and Thomas MJ: Why
targeting HDL should work as a therapeutic tool, but has not. J
Cardiovasc Pharmacol. 62:239–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsieh JY, Chang CT, Huang MT, Chang CM,
Chen CY, Shen MY, Liao HY, Wang GJ, Chen CH, Chen CJ, et al:
Biochemical and functional characterization of charge-defined
subfractions of high-density lipoprotein from normal adults. Anal
Chem. 85:11440–11448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davidson WS, Silva RA, Chantepie S, Lagor
WR, Chapman MJ and Kontush A: Proteomic analysis of defined HDL
subpopulations reveals particle-specific protein clusters:
Relevance to antioxidative function. Arterioscler Thromb Vasc Biol.
29:870–876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Patel B and Markus HS: Magnetic resonance
imaging in cerebral small vessel disease and its use as a surrogate
disease marker. Int J Stroke. 6:47–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Turin TC, Kita Y, Rumana N, Nakamura Y,
Takashima N, Ichikawa M, Sugihara H, Morita Y, Hirose K, Okayama A,
et al: Ischemic stroke subtypes in a Japanese population: Takashima
Stroke Registry, 1988–2004. Stroke. 41:1871–1876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu D, Ji L, Tong X, Pan B, Han JY, Huang
Y, Chen YE, Pennathur S, Zhang Y and Zheng L: Human apolipoprotein
A-I induces cyclooxygenase-2 expression and prostaglandin I-2
release in endothelial cells through ATP-binding cassette
transporter A1. Am J Physiol Cell Physiol. 301:C739–C748. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eng JK, McCormack AL and Yates JR: An
approach to correlate tandem mass spectral data of peptides with
amino acid sequences in a protein database. J Am Soc Mass Spectrom.
5:976–989. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kimura T, Tomura H, Mogi C, Kuwabara A,
Damirin A, Ishizuka T, Sekiguchi A, Ishiwara M, Im DS, Sato K, et
al: Role of scavenger receptor class B type I and sphingosine
1-phosphate receptors in high density lipoprotein-induced
inhibition of adhesion molecule expression in endothelial cells. J
Biol Chem. 281:37457–37467. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
32
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering
C, et al: STRING v9.1: Protein-protein interaction networks, with
increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar :
|
|
33
|
Gordon SM, Deng J, Lu LJ and Davidson WS:
Proteomic characterization of human plasma high density lipoprotein
fractionated by gel filtration chromatography. J Proteome Res.
9:5239–5249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bernelot Moens SJ, van Capelleveen JC and
Stroes ESG: Inhibition of ApoCIII: The next CSK9? Curr Opin
Lipidol. 25:418–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawakami A and Yoshida M: Apolipoprotein
CIII links dyslipidemia with atherosclerosis. J Atheroscler Thromb.
16:6–11. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feig JE, Shamir R and Fisher EA:
Atheroprotective effects of HDL: Beyond reverse cholesterol
transport. Curr Drug Targets. 9:196–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ansell BJ, Fonarow GC and Fogelman AM: The
paradox of dysfunctional high-density lipoprotein. Curr Opin
Lipidol. 18:427–434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Watson AD, Berliner JA, Hama SY, La Du BN,
Faull KF, Fogelman AM and Navab M: Protective effect of high
density lipoprotein associated paraoxonase. Inhibition of the
biological activity of minimally oxidized low density lipoprotein.
J Clin Invest. 96:2882–2891. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Blokhina O, Virolainen E and Fagerstedt
KV: Antioxidants, oxidative damage and oxygen deprivation stress: A
review. Ann Bot (Lond). 91:179–194. 2003. View Article : Google Scholar
|
|
40
|
Katoh N and Nakagawa H: Detection of
haptoglobin in the high-density lipoprotein and the very
high-density lipoprotein fractions from sera of calves with
experimental pneumonia and cows with naturally occurring fatty
liver. J Vet Med Sci. 61:119–124. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nielsen MJ, Petersen SV, Jacobsen C, Oxvig
C, Rees D, Møller HJ and Moestrup SK: Haptoglobin-related protein
is a high-affinity hemoglobin-binding plasma protein. Blood.
108:2846–2849. 2006. View Article : Google Scholar : PubMed/NCBI
|
